From biochemicals to advanced materials, unique products and solutions for every research need
Curated bioactive libraries containing validated compounds, published HTS hits, and FDA-approved therapeutics for rapid hit identification.
AQura Bio. offers a comprehensive collection of bioactive compound libraries built from molecules with well-characterised biological activity, spanning published HTS hits, annotated tool compounds, clinical candidates, and FDA-approved drugs.
Each library is curated using data from peer-reviewed studies, biochemical profiling, target-class annotations, and mechanistic insights to ensure high confidence in biological relevance. With broad coverage across key pathways - including kinases, GPCRs, epigenetic modulators, and oncology-relevant targets - these libraries provide robust starting points for hit validation, assay development, phenotypic screening, and MoA studies.
Designed for reliable performance and translational impact, AQura Bio.’s bioactive libraries enable researchers and decision-makers to rapidly benchmark assays, deconvolute phenotypes, and accelerate progression toward druggable, therapeutically meaningful leads.
Contact us for further information.